Stock 300702 ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Tianyu Pharmaceutical Co., Ltd.

Equities

300702

CNE1000034X1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
20.69 CNY -0.77% Intraday chart for Zhejiang Tianyu Pharmaceutical Co., Ltd. +0.63% -4.70%
May. 06 China Approves Tianyu Pharma's Heart Medication MT
Apr. 25 Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Zhejiang Tianyu Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of chemical raw materials. The Company operates three segments. The Pharmaceutical Intermediates segment include hypertension drugs raw materials, anti-asthma drugs raw materials and anticoagulant drugs raw materials. The Active Pharmaceutical Ingredients (API) segment is engaged in production of high blood pressure drug intermediates, anti-asthma drug intermediates and antiviral drug intermediates. The Company also operates Other segment. The Company sells its products to both domestic and international markets, including Europe, the United States, Japan, South Korea and so on.

Number of employees: 5,070

Sales per Business

CNY in Million2022Weight2023Weight Delta
Antihypertensive Active Pharmaceutical Ingredients and Intermediates
64.4 %
1,991 74.7 % 1,627 64.4 % -18.28%
Anticoagulant Active Pharmaceutical Ingredients and Intermediates
13.9 %
204 7.7 % 350 13.9 % +71.55%
Other
7.5 %
149 5.6 % 188 7.5 % +26.16%
Anti-asthma Active Pharmaceutical Ingredients and Intermediates
6.7 %
139 5.2 % 170 6.7 % +22.34%
Hypoglycemic Active Pharmaceutical Ingredients and Intermediates
3.5 %
111 4.2 % 88 3.5 % -20.89%
Blood Lipid-lowering Active Pharmaceutical Ingredients and Intermediates
2.3 %
- - 59 2.3 % -
Antiviral Active Pharmaceutical Ingredients and Intermediates
1.8 %
72 2.7 % 45 1.8 % -37.56%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
2,667 100.0 % 2,527 100.0 % -5.23%

Managers

Managers TitleAgeSince
Yong Jun Tu CEO
 Chief Executive Officer 61 03-01-31
Xiu Juan Wang DFI
 Director of Finance/CFO 39 21-04-18
Xiu Lin Wang BRD
 Director/Board Member 52 -
Lu Lu Jiang IRC
 Investor Relations Contact - -
Yan Wang SEC
 Corporate Secretary 44 10-02-28

Members of the board

Members of the board TitleAgeSince
Guo Yun Zhang BRD
 Director/Board Member 49 22-05-12
Yong Jun Tu CEO
 Chief Executive Officer 61 03-01-31
Jie Lin BRD
 Director/Board Member 55 03-01-31
Cheng Ma CHM
 Chairman 54 11-04-30
Xiu Lin Wang BRD
 Director/Board Member 52 -
Wei Guo Yang BRD
 Director/Board Member 57 11-04-30
Jin Juan Shi BRD
 Director/Board Member 48 22-05-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 350,380,802 133,797,307 ( 38.19 %) 2,403,643 ( 0.6860 %) 38.19 %

Shareholders

NameEquities%Valuation
Jie Lin
14.96 %
30,507,119 14.96 % 81 M ¥
Yong Jun Tu
6.999 %
14,277,353 6.999 % 38 M ¥
Shan Zeng Tu
5.137 %
10,479,056 5.137 % 28 M ¥
Guotai Asset Management Co., Ltd.
3.191 %
6,509,180 3.191 % 17 M ¥
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
1.178 %
2,403,643 1.178 % 6 M ¥
Taikang Asset Management Co. Ltd.
1.051 %
2,144,819 1.051 % 6 M ¥
CIB Fund Management Co., Ltd.
0.7690 %
1,568,600 0.7690 % 4 M ¥
Caitong Securities Asset Management Co., Ltd.
0.7229 %
1,474,500 0.7229 % 4 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.5147 %
1,050,000 0.5147 % 3 M ¥
Hwabao WP Fund Management Co., Ltd.
0.3420 %
697,700 0.3420 % 2 M ¥
NameEquities%Valuation
Jie Lin
63.56 %
91,521,355 63.56 % 242 M ¥
Yong Jun Tu
29.75 %
42,832,056 29.75 % 113 M ¥

Holdings

NameEquities%Valuation
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
1.18%
 2,403,643 1.18% 6,346,435 $

Company contact information

Zhejiang Tianyu Pharmaceutical Co., Ltd.

Huangyan Jiangkou Chemical Dev Zone

318020, Taizhou

+

http://www.tianyupharm.com
address Zhejiang Tianyu Pharmaceutical Co., Ltd.(300702)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Ratings for Zhejiang Tianyu Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.69 CNY
Average target price
22.6 CNY
Spread / Average Target
+9.23%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Stock Zhejiang Tianyu Pharmaceutical Co., Ltd.
-4.70% 993M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.98% 43.92B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.56% 23.09B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.25% 15.35B
CIPLA LIMITED Stock Cipla Limited
+14.03% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+46.40% 12.02B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.14% 7B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.88% 5.6B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300702 Stock
  4. Company Zhejiang Tianyu Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW